Bamlanivimab is a fully human monoclonal antibody targeting the spike protein of SARS-CoV-2. It was the first anti-COVID-19 antibody to receive Emergency Use Authorization (EUA) from the U.S. FDA. Bamlanivimab binds to the receptor-binding domain (RBD) of the spike protein, neutralizing viral entry into host cells. It is a valuable tool for research on viral infection mechanisms, therapeutic neutralization, and emerging variant resistance.
Bamlanivimab is a fully human monoclonal antibody targeting the spike protein of SARS-CoV-2. It was the first anti-COVID-19 antibody to receive Emergency Use Authorization (EUA) from the U.S. FDA. Bamlanivimab binds to the receptor-binding domain (RBD) of the spike protein, neutralizing viral entry into host cells. It is a valuable tool for research on viral infection mechanisms, therapeutic neutralization, and emerging variant resistance.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
